Virulence markers of Helicobacter pylori in patients with diarrhoea-dominant irritable bowel syndrome

British Journal of Biomedical Science

Volumn 69, Issue 1, 2012, Pages 6-10

  Yakoob, Javed ^a   Abbas, Z ^a   Naz, S ^a   Islam, M ^a   Jafri, W ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

cagA; Helicobacter pylori; Irritable bowel syndrome; vacA alleles

Indexed keywords

VIRULENCE FACTOR;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CAGA GENE; CONTROLLED STUDY; DIARRHEA; FEMALE; GENETIC MARKER; HELICOBACTER PYLORI; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; VACA GENE;

HELICOBACTER PYLORI;

EID: 84860814512     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2012.11669914     Document Type: Article

References (28)

1. Monack DM, Mueller A, Falkow S. Persistent bacterial infections: the interface of the pathogen and the host immune system. Nat Rev Microbiol 2004; 2 (9): 747-65. (Pubitemid 39200066)
2. Tsuji S, Kawano S. Peptic ulcer recurrence and Helicobacter pylori: evidence from Japan. J Gastroenterol 2003; 38 (4): 410-1. (Pubitemid 36626282)
3. Blaser MJ, Perez-Perez GI, Kleanthous H et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55 (10): 2111-5.
4. Stead RH, Hewlett BR, Lhotak S, Colley ECC, Frendo M, Dixon MT. Do gastric mucosal nerves remodel in H. pylori gastritis? In: Hunt RH, Tytgat GNJ eds. Helicobacter pylori: basic mechanism to clinical cure. Dordrecht: Kluwer Academic Publishers, 1994: 281-91.
5. Mayer EA, Gebhart GF. Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 1994; 107 (1): 271-93. (Pubitemid 24195371)
6. Nakajima S, Nakajima S, Hattori T, Krishnan B, Ota H, El-Zimaity HM. Distribution of smooth muscle bundles in gastric mucosa with or without Helicobacter pylori infection and their relationship with mast cells. Gastroenterology 1998; 114 (Suppl 1): A239.
7. Shaffer SE, Felis MR. Decreased cholinergic and excitatory neural responsiveness of smooth muscle in a model of Helicobacter gastritis. Gastroenterology 1996; 110 (Suppl 1): A756.
8. Censini S, Lange C, Xiang Z et al. cag, a pathogenecity island of H. pylori encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 1996; 93 (25): 14648-53.
9. Atherton JC, Cao P, Peek RM, Tummuru MKR, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of H. pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995; 270 (30): 17771-7.
10. Vinion-Dubiel AD, McClain MS, Czajkowsky DM et al. A dominant negative mutant of Helicobacter pylori vacuolating toxin (VacA) inhibits VacA-induced cell vacuolation. J Biol Chem 1999; 274 (53): 37736-42. (Pubitemid 30026834)
11. Szabò I, Brutsche S, Tombola F et al. Formation of anion-selective channels in the cell plasma membrane by the toxin VacA of Helicobacter pylori is required for its biological activity. EMBO J 1999; 18 (20): 5517-27. (Pubitemid 29486371)
12. Tombola F, Carlesso C, Szabò I et al. Helicobacter pylori vacuolating toxin forms anion-selective channels in planar lipid bilayers: possible implications for the mechanism of cellular vacuolation. Biophys J 1999; 76 (3): 1401-9. (Pubitemid 29262620)
13. Guarino A, Bisceglia M, Canani RB et al. Enterotoxic effect of the vacuolating toxin produced by Helicobacter pylori in Caco-2 cells. J Infect Dis 1998; 178 (5): 1373-8.
14. Pelicic V, Reyrat JM, Sartori L et al. Helicobacter pylori VacA cytotoxin associated with the bacteria increases epithelial permeability independently of its vacuolating activity. Microbiology 1999; 145 (Pt 8): 2043-50. (Pubitemid 29396934)
15. Luzzi I, Covacci A, Censini S et al. Detection of a vacuolating cytotoxin in stools from children with diarrhea. Clin Infect Dis 1996; 23 (1): 101-6.
16. Jafri W, Yakoob J, Abid S, Siddiqui S, Awan S, Nizami SQ. Helicobacter pylori infection in children: population-based age-specific prevalence and risk factors in a developing country. Acta Paediatr 2010; 99 (2): 279-82.
17. Yakoob J, Abid S, Abbas Z et al. Distribution of Helicobacter pylori virulence markers in patients with gastroduodenal diseases in Pakistan. BMC Gastroenterol 2009; 9: 87.
18. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006; 130 (5): 1480-91.
19. Price AB. The Sydney System: histological division. J Gastroenterol Hepatol 1991; 6 (3): 209-22.
20. van Zwet AA, Thijs C, Kooistra-Smid AM, Schirm J, Snijder JA. Sensitivity of culture compared with that of polymerase chain reaction for detection of Helicobacter pylori from antral biopsy samples. J Clin Microbiol 1993; 31 (7): 1918-20.
21. Fox JG, Dewhirst FE, Shen Z et al. Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. Gastroenterology 1998; 114 (4): 755-63. (Pubitemid 28160410)
22. Covacci A, Rappuoli R. PCR amplification of gene sequences from Helicobacter pylori strains. In: Lee A, Megraud F eds. Helicobacter pylori: techniques for clinical diagnosis and basic research. Philadelphia: WB Saunders, 1995: 94-109.
23. Akopyants NS, Clifton SW, Kersulyte D et al. Analyses of the cag pathogenicity island of Helicobacter pylori. Mol Microbiol 1998; 28 (1): 37-53. (Pubitemid 28160112)
24. Slater E, Owen RJ, Williams M, Pounder RE. Conservation of the cag pathogenicity island of Helicobacter pylori: associations with vacuolating cytotoxin allele and IS605 diversity. Gastroenterology 1999; 117 (6): 1308-15.
25. Hassan SR, Abbas Z. Presence of Helicobacter pylori in dyspeptic patients with endoscopically normal stomach. Pak J Med Sci Q 2007; 23: 335-9. (Pubitemid 47015983)
26. Gwee KA, Leong YL, Graham C et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999; 44 (3): 400-6. (Pubitemid 29119338)
27. Stoicov C, Whary M, Rogers AB et al. Coinfection modulates inflammatory responses and clinical outcome of Helicobacter felis and Toxoplasma gondii infections. J Immunol 2004; 173 (5): 3329-36. (Pubitemid 39142042)
28. Bercik P, Verdu EF, Collins SM. Is irritable bowel syndrome a low-grade inflammatory bowel disease? Gastroenterol Clin North Am 2005; 34 (2): 235-45. (Pubitemid 40615953)